Sunshine Biopharma Inc.
SBFMNasdaqCIK 1402328HealthcareFiscal year ends Dec 31
Reports and events: 192 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-04-2316:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-24-002616 |
| 2024-04-0114:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-001993 |
| 2024-03-2816:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001683168-24-001818 |
| 2024-03-0616:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.07 Shareholder vote results | 0001683168-24-001357 |
| 2024-03-0116:19 ET | 8-K | 3.01 Delisting notice | 0001683168-24-001253 |
| 2024-02-1617:01 ET | 8-K | 5.07 Shareholder vote results | 0001683168-24-001049 |
| 2024-02-1511:39 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-001009 |
| 2024-02-1209:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-24-000865 |
| 2024-02-0917:17 ET | S-1/A | Registration statement, amended | 0001683168-24-000849 |
| 2024-02-0116:17 ET | S-1 | Registration statement | 0001683168-24-000610 |
| 2024-01-3012:38 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001683168-24-000540 |
| 2023-12-0716:59 ET | 8-K | 5.07 Shareholder vote results | 0001683168-23-008696 |
| 2023-11-1309:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-23-007924 |
| 2023-11-1308:00 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001683168-23-007911 |
| 2023-11-0212:18 ET | 8-K | 1.02 Termination of a material agreement | 0001683168-23-007582 |
| 2023-10-2013:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-23-007302 |
| 2023-10-1813:32 ET | DEF 14A | Proxy statementPeriod 2023-12-07 | 0001683168-23-007244 |
| 2023-10-1310:44 ET | 8-K | 5.07 Shareholder vote results | 0001683168-23-007129 |
| 2023-09-2221:08 ET | 8-K | 8.01 Other events | 0001683168-23-006611 |
| 2023-09-0516:20 ET | DEF 14A | Proxy statementPeriod 2023-10-12 | 0001683168-23-006264 |
| 2023-08-1109:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-23-005540 |
| 2023-08-1017:03 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001683168-23-005518 |
| 2023-05-1616:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-003473 |
| 2023-05-1116:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-23-003210 |
| 2023-05-1016:04 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001683168-23-003121 |
| 2023-04-1908:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-23-002522 |
| 2023-04-0419:20 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001683168-23-002128 |
| 2023-03-2416:45 ET | 8-K | 3.01 Delisting notice | 0001683168-23-001754 |
| 2023-02-2807:16 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-23-001172 |
| 2023-02-1314:57 ET | 8-K | 8.01 Other events | 0001683168-23-000805 |
| 2023-02-1007:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-23-000716 |
| 2022-12-1216:31 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001683168-22-008357 |
| 2022-12-0916:05 ET | 8-K | 3.01 Delisting notice | 0001683168-22-008309 |
| 2022-11-0707:30 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001683168-22-007290 |
| 2022-10-2007:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-22-006971 |
| 2022-08-0316:43 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001683168-22-005298 |
| 2022-05-0614:47 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001683168-22-003262 |
| 2022-04-2817:03 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-22-003015 |
| 2022-04-0816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-22-002473 |
| 2022-03-2416:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-22-001920 |
| 2022-03-2107:46 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001683168-22-001788 |
| 2022-03-1518:42 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-22-001654 |
| 2022-02-2508:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-22-001271 |
| 2022-02-1710:25 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-22-001090 |
| 2022-02-1406:01 ET | S-1/A | Registration statement, amended | 0001683168-22-000916 |
| 2022-02-1015:13 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-22-000840 |
| 2022-02-0917:03 ET | S-1/A | Registration statement, amended | 0001683168-22-000809 |
| 2022-02-0820:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-22-000732 |
| 2022-02-0317:31 ET | S-1/A | Registration statement, amended | 0001683168-22-000663 |
| 2022-01-2416:24 ET | S-1/A | Registration statement, amended | 0001683168-22-000418 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:50 ET. Listed shows no prices and gives no investment advice.